CALM-2

A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension

BLU-5937OngoingRecruitingPhase 3Open NCT07650084 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

CALM-2 · Trial Tracker · ComplyRx